Guangwei Xu, Tianqi Wang, Yongtao Li, Zhi Huang, Xin Wang, Jianyu Zheng, . . . Rong Xiang. (2018). A highly potent and selective inhibitor Roxyl-WL targeting IDO1 promotes immune response against melanoma. Taylor & Francis Group.
Chicago Style (17th ed.) CitationGuangwei Xu, Tianqi Wang, Yongtao Li, Zhi Huang, Xin Wang, Jianyu Zheng, Shengyong Yang, Yan Fan, and Rong Xiang. A Highly Potent and Selective Inhibitor Roxyl-WL Targeting IDO1 Promotes Immune Response Against Melanoma. Taylor & Francis Group, 2018.
MLA (9th ed.) CitationGuangwei Xu, et al. A Highly Potent and Selective Inhibitor Roxyl-WL Targeting IDO1 Promotes Immune Response Against Melanoma. Taylor & Francis Group, 2018.
Warning: These citations may not always be 100% accurate.